Literature DB >> 9659764

Varicella-zoster virus infection in Australia.

K G Chant1, E A Sullivan, M A Burgess, M J Ferson, J M Forrest, L M Baird, D I Tudehope, M Tilse.   

Abstract

OBJECTIVE: To determine the epidemiology of varicella-zoster virus (VZV) infection in Australia using currently available data sources.
DESIGN: Analysis of national death data (23 years), congenital and neonatal cases (one year) and attendances at sentinel general practices (two years); hospital admissions in NSW and SA (six years); serological studies in 1995 involving antenatal clinics in Sydney and Brisbane and child-care centre staff and refugees in Sydney; and case-ascertainment in 1995 in South Western Sydney among public hospital staff, child-care centre staff and the community.
RESULTS: In Australia, there have been an average of 3.5 deaths from chickenpox (mostly children) and 11 from herpes zoster (mostly older people) each year since 1980. The crude death rate for chickenpox has declined (p > 0.05). In 1995, there were 14 cases of neonatal and two of congenital varicella. Average annual admission rates for NSW and SA showed 1,200 hospital bed-days used for chickenpox, more than 20% with complications, and more than 7,300 bed days for zoster; annually more than 880 in-patient admissions were complicated by VZV. Most people encounter the virus in their first 15 years, but some remain susceptible into their 20s; 25% of cases and 37% of hospital admissions for chickenpox occur in people > or = 15 years of age.
CONCLUSION: VZV infection involves people of all ages. It causes substantial morbidity and mortality, particularly at the extremes of life. The death rate from chickenpox but not zoster has fallen since the introduction of acyclovir in the 1980s. Surveillance of VZV infection must be given priority once vaccines become available, to monitor changes in morbidity and mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9659764     DOI: 10.1111/j.1467-842x.1998.tb01405.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  7 in total

1.  Epidemiological Study on the Incidence of Herpes Zoster in Nearby Cheonan.

Authors:  Ho Soon Jung; Jin Ku Kang; Sie Hyeon Yoo
Journal:  Korean J Pain       Date:  2015-07-01

Review 2.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  The burden of varicella in Germany. Potential risks and economic impact.

Authors:  Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Thomas Hammerschmidt; Peter Wutzler
Journal:  Eur J Health Econ       Date:  2004-02

Review 5.  Herpes zoster-associated mortality in Europe: a systematic review.

Authors:  Hélène Bricout; Margaret Haugh; Olugbenga Olatunde; Ruth Gil Prieto
Journal:  BMC Public Health       Date:  2015-05-05       Impact factor: 3.295

6.  Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella.

Authors:  Igor A Korostil; James G Wood; David G Regan
Journal:  Theor Biol Med Model       Date:  2015-04-11       Impact factor: 2.432

Review 7.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.